Jay Olson

Jay Olson is an experienced Research Analyst at Oppenheimer & Co. Inc., specializing in investment research for SMID-cap biotechnology since August 2016. Prior to this role, Jay Olson worked at Goldman Sachs in Equity Research focused on Major and Specialty Pharma from July 2012 to August 2016, and at Sanford C. Bernstein from May 2008 to July 2012, where contributions included providing insights into the pharmaceutical industry and conducting in-depth research on various disease areas. Jay Olson's career began at Pfizer, serving as Marketing Director from 1990 to 2006 for products such as Viagra and Zoloft, followed by a Director position at Allergan, overseeing new product opportunities in multiple therapeutic areas from June 2006 to May 2008. Jay Olson holds an MBA in Finance and Marketing from MIT Sloan School of Management, alongside a Master's in Chemical Engineering from the Massachusetts Institute of Technology and a Bachelor's in Chemical Engineering from Tufts University.